SUPRIYAPharmaceuticals
Supriya Lifescience Ltd — Balance Sheet
₹561.90
-1.58%
Supriya Lifescience Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 8.05 Cr | 8.05 Cr | 8.05 Cr | 8.05 Cr | — |
| Share Issued | 8.05 Cr | 8.05 Cr | 8.05 Cr | 8.05 Cr | — |
| Total Debt | 5.38 Cr | 5.49 Cr | 22.47 Cr | 27.41 Cr | — |
| Tangible Book Value | 995.37 Cr | 813.71 Cr | 698.44 Cr | 614.18 Cr | — |
| Invested Capital | 996.76 Cr | 815.37 Cr | 716.08 Cr | 636.98 Cr | — |
| Working Capital | 354.88 Cr | 320.91 Cr | 369.11 Cr | 397.85 Cr | — |
| Net Tangible Assets | 995.37 Cr | 813.71 Cr | 698.44 Cr | 614.18 Cr | — |
| Capital Lease Obligations | 5.38 Cr | 5.49 Cr | 5.84 Cr | 6.12 Cr | — |
| Common Stock Equity | 996.76 Cr | 815.37 Cr | 699.46 Cr | 615.69 Cr | — |
| Total Capitalization | 996.76 Cr | 815.37 Cr | 699.46 Cr | 615.69 Cr | — |
| Total Equity Gross Minority Interest | 996.76 Cr | 815.37 Cr | 699.46 Cr | 615.69 Cr | — |
| Stockholders Equity | 996.76 Cr | 815.37 Cr | 699.46 Cr | 615.69 Cr | — |
| Other Equity Interest | 980.66 Cr | 799.27 Cr | 683.36 Cr | 599.59 Cr | — |
| Capital Stock | 16.10 Cr | 16.10 Cr | 16.10 Cr | 16.10 Cr | — |
| Common Stock | 16.10 Cr | 16.10 Cr | 16.10 Cr | 16.10 Cr | — |
| Total Liabilities Net Minority Interest | 115.55 Cr | 105.87 Cr | 120.82 Cr | 119.08 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 33.39 Cr | 28.98 Cr | 25.04 Cr | 19.38 Cr | — |
| Other Non Current Liabilities | -10000.00 | 7000.00 | -4000.00 | 10000.00 | — |
| Non Current Deferred Taxes Liabilities | 27.02 Cr | 23.15 Cr | 13.68 Cr | 11.15 Cr | — |
| Long Term Debt And Capital Lease Obligation | 5.06 Cr | 5.02 Cr | 5.49 Cr | 5.29 Cr | — |
| Long Term Capital Lease Obligation | 5.06 Cr | 5.02 Cr | 5.49 Cr | 5.29 Cr | — |
| Long Term Provisions | 1.32 Cr | 0.80 Cr | 5.88 Cr | 2.93 Cr | — |
| Current Liabilities | 82.16 Cr | 76.89 Cr | 95.78 Cr | 99.70 Cr | — |
| Other Current Liabilities | 4.34 Cr | 2.73 Cr | 2.82 Cr | 3.16 Cr | — |
| Current Debt And Capital Lease Obligation | 0.32 Cr | 0.47 Cr | 16.98 Cr | 22.12 Cr | — |
| Current Capital Lease Obligation | 0.32 Cr | 0.47 Cr | 0.35 Cr | 0.82 Cr | — |
| Current Debt | 0.00 | 0.00 | 16.63 Cr | 21.30 Cr | — |
| Current Provisions | 1.19 Cr | 0.36 Cr | — | — | — |
| Payables | 74.55 Cr | 60.57 Cr | 65.05 Cr | 49.77 Cr | — |
| Accounts Payable | 74.55 Cr | 59.57 Cr | 64.23 Cr | 48.97 Cr | — |
| Total Assets | 1.11K Cr | 921.24 Cr | 820.28 Cr | 734.76 Cr | — |
| Total Non Current Assets | 675.28 Cr | 523.43 Cr | 355.39 Cr | 237.22 Cr | — |
| Other Non Current Assets | 11.15 Cr | 10000.00 | 0.09 Cr | -10000.00 | — |
| Investmentin Financial Assets | 63.24 Cr | 61.08 Cr | 25.09 Cr | 0.05 Cr | — |
| Goodwill And Other Intangible Assets | 1.39 Cr | 1.66 Cr | 1.02 Cr | 1.51 Cr | — |
| Gross PPE | 599.49 Cr | 516.03 Cr | 371.35 Cr | 263.57 Cr | — |
| Construction In Progress | 148.01 Cr | 148.82 Cr | 67.63 Cr | 43.41 Cr | — |
| Other Properties | 451.48 Cr | 48.83 Cr | 45.34 Cr | 25.22 Cr | — |
| Current Assets | 437.04 Cr | 397.80 Cr | 464.89 Cr | 497.54 Cr | — |
| Other Current Assets | 103.53 Cr | 120.72 Cr | -20000.00 | 30000.00 | — |
| Inventory | 118.35 Cr | 85.25 Cr | 115.77 Cr | 92.31 Cr | — |
| Other Receivables | 0.93 Cr | 5.19 Cr | 6.96 Cr | 23.98 Cr | — |
| Accounts Receivable | 134.36 Cr | 111.68 Cr | 84.66 Cr | 115.18 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 79.86 Cr | 72.74 Cr | 154.45 Cr | 224.93 Cr | — |
| Other Short Term Investments | 3.81 Cr | 4.57 Cr | 69.20 Cr | 59.16 Cr | — |
| Cash And Cash Equivalents | 76.06 Cr | 68.17 Cr | 85.25 Cr | 165.78 Cr | — |
| Net PPE | 599.49 Cr | 457.30 Cr | 328.06 Cr | 231.67 Cr | — |
| Retained Earnings | — | 600.45 Cr | 486.16 Cr | 401.13 Cr | 253.72 Cr |
| Additional Paid In Capital | — | 198.54 Cr | 198.54 Cr | 198.54 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | 0.80 Cr | 5.88 Cr | 2.93 Cr | 1.30 Cr |
| Long Term Debt | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Deferred Taxes Liabilities | — | -2.68 Cr | 4.59 Cr | 6.41 Cr | 15.20 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.36 Cr | 0.84 Cr | 0.41 Cr | 0.91 Cr |
| Other Payable | — | 1.00 Cr | 0.82 Cr | 0.79 Cr | 0.57 Cr |
| Dividends Payable | — | 0.00 | 0.00 | 0.00 | — |
| Non Current Prepaid Assets | — | 0.68 Cr | 0.93 Cr | 3.98 Cr | 1.13 Cr |
| Available For Sale Securities | — | 61.08 Cr | 25.09 Cr | 0.05 Cr | 0.05 Cr |
| Other Intangible Assets | — | 1.66 Cr | 1.02 Cr | 1.51 Cr | 1.61 Cr |
| Accumulated Depreciation | — | -58.73 Cr | -43.29 Cr | -31.90 Cr | -22.17 Cr |
| Machinery Furniture Equipment | — | 222.20 Cr | 176.81 Cr | 131.10 Cr | 69.86 Cr |
| Buildings And Improvements | — | 85.77 Cr | 72.42 Cr | 54.68 Cr | 28.30 Cr |
| Land And Improvements | — | 10.42 Cr | 9.16 Cr | 9.16 Cr | 7.79 Cr |
| Current Deferred Assets | — | 0.69 Cr | 0.00 | — | — |
| Restricted Cash | — | 2.22 Cr | 3.13 Cr | 2.98 Cr | 2.85 Cr |
| Prepaid Assets | — | 120.03 Cr | 99.92 Cr | 38.16 Cr | 9.54 Cr |
| Other Inventories | — | 0.05 Cr | — | — | — |
| Finished Goods | — | 21.54 Cr | 25.77 Cr | 17.95 Cr | 22.42 Cr |
| Work In Process | — | 3.91 Cr | 29.99 Cr | 31.30 Cr | 23.80 Cr |
| Raw Materials | — | 59.75 Cr | 60.01 Cr | 43.06 Cr | 26.25 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.74 Cr | -1.06 Cr | -1.41 Cr | -1.04 Cr |
| Gross Accounts Receivable | — | 112.43 Cr | 85.73 Cr | 116.59 Cr | 74.54 Cr |
| Cash Equivalents | — | 56.53 Cr | 77.43 Cr | 142.62 Cr | 42.62 Cr |
| Cash Financial | — | 11.63 Cr | 7.82 Cr | 23.16 Cr | 0.88 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt | — | — | — | — | 26.63 Cr |
| Non Current Deferred Revenue | — | — | — | — | 0.00 |
| Total Tax Payable | — | — | — | — | 15.19 Cr |
| Taxes Receivable | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Supriya Lifescience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.